Header

Introducing Compounded Pimobendan Injection Solution

Wedgewood's Pimobendan Injection Solution is a US-compounded medication for the emergency treatment of canine patients in acute decompensated congestive heart failure (ADHF) due to MMVD or DCM. Available for office stock, it gives your team an IV option for use in emeergency situations.

Pimobendan Injection Solution

Pimobendan Injection Solution

An IV option for the acute moment. On your shelf, ready when your patient needs it.

Product Details
Strength0.75mg/ml
Size10ml
FormPreservative-free, single-dose vial
StorageRefrigerated
BUD60 days
OrderingOffice Stock* or Prescription

For when oral administration isn't an option

Wedgewood's compounded pimobendan injection gives your team an option in the moments oral dosing doesn't fit the patient in front of you.

When a patient is oxygen dependent

When hemodynamic changes make oral absorption unpredictable

When immediate therapy is needed

Wedgewood's Injectable Pimobendan

US-compounded. Available for office stock in most states. On the shelf when it's needed.

Personalized Support for Complex Cases

Acute decompensated heart failure presentations vary, so should your options. Our pharmacists are available to consult on dosing context, HD label handling, and formulary onboarding.

FAQs

When should a veterinarian choose the injectable over oral pimobendan?

Can this replace chronic oral maintenance therapy?

Can my practice order Pimobendan Injection Solution for office stock, or only patient-specific prescriptions?

What is the Beyond-Use Date?

What does the HD label mean? Is this medication hazardous?

*Office stock availability subject to state restrictions.